SA
PRME icon

Sanctuary Advisors’s Prime Medicine PRME Stock Holding History

Sanctuary Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.4K Sell
13,894
-765
-5% -$2.91K ﹤0.01% 2492
2025
Q4 		$50.9K Buy
14,659
+336
+2% +$1.5K ﹤0.01% 2384
2025
Q3 		$79.3K Buy
+14,323
New +$58.2K ﹤0.01% 2362
2025
Q2 		– Sell
-23,822
Closed -$47.4K – 2431
2025
Q1 		$47.4K Buy
+23,822
New +$60.8K ﹤0.01% 2145

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Sanctuary Advisors's PRME Position: Q1 2026 in Review

Sanctuary Advisors reduced its Prime Medicine (PRME) stake by 5.2% in Q1 2026, selling an estimated $2.91K and leaving 13,894 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

Sanctuary Advisors first reported a position in PRME in Q1 2025 and has held it in 4 quarters since. The position peaked at $79.3K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Sanctuary Advisors held 13,894 shares of Prime Medicine worth $48.4K as of Q1 2026.
  • Sanctuary Advisors sold 765 Prime Medicine shares in Q1 2026, an estimated $2.91K.
  • Prime Medicine made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2492 holding.
  • Sanctuary Advisors first reported a position in Prime Medicine in Q1 2025 and has held it in 4 quarters since.
  • Sanctuary Advisors's Prime Medicine position peaked at $79.3K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.